Achieving donor-specific hyporesponsiveness is associated with FOXP3 + regulatory T cell recruitment in human renal allograft infiltrates

Journal of Immunology

Volumn 179, Issue 7, 2007, Pages 4901-4909

  Bestard, Oriol ^a   Cruzado, Josep M ^a   Mestre, Mariona ^a   Caldés, Anna ^a   Bas, Jordi ^a   Carrera, Marta ^a   Torras, Joan ^a   Rama, Inés ^a   Moreso, Francesc ^a   Serón, Daniel ^a   Grinyó, Josep M ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; GANCICLOVIR; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; STEROID; THYMOCYTE ANTIBODY; TRANSCRIPTION FACTOR FOXP3; VALGANCICLOVIR;

ACUTE GRAFT REJECTION; ADULT; ALLOIMMUNITY; ANTIGEN SPECIFICITY; APOPTOSIS; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; FEMALE; GRAFT RECIPIENT; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; HUMORAL IMMUNITY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT; KIDNEY DONOR; KIDNEY FUNCTION; KIDNEY INJURY; LOW DRUG DOSE; MALE; PERIPHERAL LYMPHOCYTE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE;

ANIMALS; APOPTOSIS; BIOPSY; FEMALE; FOLLOW-UP STUDIES; FORKHEAD TRANSCRIPTION FACTORS; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FUNCTION TESTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; T-LYMPHOCYTES, REGULATORY; TRANSPLANTATION, HOMOLOGOUS;

EID: 36249005633     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.179.7.4901     Document Type: Article

References (53)

1. Kawai, T., A. B. Cosimi, R. B. Colvin, J. Powelson, J. Eason, T. Kozlowski, M. Sykes, R. Monroy, M. Tanaka, and D. H. Sachs. 1995. Mixed allogeneic chimerism and renal allograft tolerance in cynomolgus monkeys. Transplantation 59: 256-262.
2. Levisetti, M. G., P. A. Padrid, G. L. Szot, N. Mittal, S. M. Meehan, C. L. Wardrip, G. S. Gray, D. S. Bruce, J. R. Thistlethwaite, and J. A. Bluestone. 1997. Immunosuppressive effects of human CTLA4Ig in a non-human primate model of allogeneic pancreatic islet transplantation. J. Immunol. 159: 5187-5191.
3. Kimikawa, M., D. H. Sachs, R. B. Colvin, A. Bartholomew, T. Kawai, and A. B. Cosimi. 1997. Modifications of the conditioning regimen for achieving mixed chimerism and donor-specific tolerance in cynomolgus monkeys. Transplantation 64: 709-716.
4. Kawai, T., A. Poncelet, D. H. Sachs, S. Mauiyyedi, S. Boskovic, S. L. Wee, D. S. Ko, A. Bartholomew, M. Kimikawa, H. Z. Hong, et al. 1999. Long-term outcome and alloantibody production in a non-myeloablative regimen for induction of renal allograft tolerance. Transplantation 68: 1767-1775.
5. Thomas, J. M., J. L. Contreras, X. L. Jiang, D. E. Eckhoff, P. X. Wang, W. L. Hubbard, A. L. Lobashevsky, W. Wang, C. Asiedu, S. Stavrou, et al. 1999. Peritransplant tolerance induction in macaques: early events reflecting the unique synergy between immunotoxin and deoxyspergualin. Transplantation 68: 1660-1673.
6. Thomas, J. M., D. E. Eckhoff, J. L. Contreras, A. L. Lobashevsky, W. J. Hubbard, J. K. Moore, W. J. Cook, F. T. Thomas, and D. M. Neville, Jr. 2000. Durable donor-specific T and B cell tolerance in Rhesus macaques induced with peri-transplantation anti-CD3 immunotoxin and deoxyspergualin: absence of chronic allograft nephropathy. Transplantation 69: 2497-2503.
7. Thomas, J. M., J. L. Contreras, C. A. Smyth, A. Lobashevsky, S. Jenkins, W. J. Hubbard, D. E. Eckhoff, S. Stavrou, D. M. Neville, Jr., and F. T. Thomas. 2001. Successful reversal of streptozotocin-induced diabetes with stable allogeneic islet function in a preclinical model of type 1 diabetes. Diabetes 50: 1227-1236.
8. Adams, A. B., N. Shirasugi, M. M. Durham, E. Strobert, D. Anderson, P. Rees, S. Cowan, H. Xu, Y. Blinder, M. Cheung, et al. 2002. Calcineurin inhibitor-free CD28 blockade-based protocol protects allogeneic islets in nonhuman primates. Diabetes 51: 265-270.
9. Torrealba, J. R., L. A. Fernandez, T. Kanmaz, T. D. Oberley, J. M. Schultz, K. G. Brunner, D. Peters, J. H. Fechner, Jr., Y. Dong, H. Hu, et al. 2003. Immunotoxin-treated Rhesus monkeys: a model for renal allograft chronic rejection. Transplantation 76: 524-530.
10. Kawai, T., H.- Sogawa, S. Boskovic, G. Abrahamian, R. N. Smith, S. L. Wee, D. Andrews, O. Nadazdin, I. Koyama, M. Sykes, et al. 2004. CD154 blockade for induction of mixed chimerism and prolonged renal allograft survival in nonhuman primates. Am. J. Transplant. 4: 1391-1398.
11. + T regulatory cell infiltrates. J. Immunol. 172: 5753-5764.
12. Larsen, C. P., T. C. Pearson, A. B. Adams, P. Tso, N. Shirasugi, E. Strobertm, D. Anderson, S. Cowan, K. Price, J. Naemura, et al. 2005. Rational development of LEA29Y (belatacept), a high-affinity variant of CTLA4-Ig with potent immunosuppressive properties. Am. J. Transplant. 5: 443-453.
13. Starlz, T. E., and R. Zinkernagel. 2001. Transplantation tolerance from a historical perspective. Nat. Rev. 1: 233-239.
14. Shapiro, R., M. Jordan, A. Basu, V. Scantlebury, S. Potdar, H. P. Tan, E. Gray, P. Randhawa, N. Murase, A. Zeevi, et al. 2003. Kidney transplantation under a tolerogenic regimen of recipient pretreatment and low-dose postoperative immunosuppression with subsequent weaning. Ann. Surg. 238: 520-527.
15. Knechtle, S. J., J. D. Pirsch, J. H. Fechner, Jr., B. N. Becker, A. Friedl, R. B. Colvin, L. K. Lebeck, L. T. Chin, Y. T. Becker, J. S. Odorico, et al. 2003. Campath-1H induction plus rapamycin monotherapy for renal transplantation: results of a pilot study. Am. J. Transplant. 3: 722-730.
16. Noris, M., F. Casiraghi, M. Todeschini, P. Cravedi, D. Cugini, G. Monteferrante, S. Aiello, L. Cassis, E. Gotti, F. Gaspari, et al. 2007. Regulatory T cells and T cell depletion: role of immunossuppressive drugs. J. Am. Soc. Nephrol. 18: 1007-1018.
17. De Ruvo, N., A. Cucchetti, A. Lauro, N. Cautero, F. Di Benedetto, A. Dazzi, M. Ravaioli, F. Di Francesco, G. Molteni, G. Ramacciato, et al. 2005. Preliminary results of a "prope" tolerogenic regimen with thymoglobulin pretreatment and hepatitis C virus recurrance in liver transplantation. Transplantation 80: 8-12.
18. + regulatory T cell function by calcineurin dependent interleukin-2 production. Blood 109: 2649-2656.
19. Kawai, M., H. Kitade, C. Mathieu, M. Waer, and J. Pirenne. 2005. Inhibitory and stimulatory effects of cyclosporine A on the development of regulatory T cells in vivo. Transplantation 79: 1073-1077.
20. Gao, W., Y. Lu, B. E. Essawy, M. Oukka, V. K. Kuchroom, and T. B. Strom. 2007. Contrasting effects of cyclosporine and rapamycin in de novo generation of alloantigen-specific regulatory T cells. J. Am. Soc. Nephrol. 7: 1-11.
21. Starlz, T. E., and R. Zinkernagel. 1998. Antigen localization and migration in immunity and tolerance. N. Engl. J. Med. 339: 1905-1913.
22. Preville, X., M. Flacher, B. LeMauff, S. Beauchard, P. Davelu, J. Tiollier, and J. P. Revillard. 2001. Mechanisms involved in antithymocyte globulin immunosuppressive activity in a nonhuman primate model. Transplantation. 71: 460-468.
23. + T cells in the periphery. Transplantation 77: 183-189.
24. + regulatory T cells. Blood 105: 4743-4748.
25. + regulatory T cells. J. Am. Soc. Nephrol. 17: 2844-2853.
26. + regulatory T cells cultured with rapamycin. J. Immunol. 178: 320-329.
27. Terasaki, P. I., and M. Ozawa. 2005. Predictive value of HLA antibodies and serum creatinine in chronic rejection: results of a 2-year prospective trial. Transplantation 80: 1194-1197.
28. Rifle, G., C. Mousson, L. Martin, F. Guignier, and K. Hajji. 2005. Donor-specific antibodies in allograft rejection: clinical and experimental data. Transplantation 79: S14-S18.
29. Hricik, D. E., V. Rodriguez, J. Riley, K. Bryan, M. Tary-lehmann, N. S. Greenspan, C. Dejelo, J. A. Schulak, and P. S. Heeger. 2003. Enzyme-linked immunosorbent spot (ELISPOT) assay for interferon-γ independently predicts renal function in kidney transplant recipients. Am. J. Transplant. 3: 878-884.
30. Nickel, P., F. Presber, G. Bold, D. Biti, C. Schönemann, S. G. Tullius, H. D. Volk, and P. Reinke. 2004. Enzyme-linked immunosorbent spot assay for donor-reactive interferon-γ-producing cells identifies T-cell presensitization and correlates with graft function at 6 and 12 month in renal-transplant patients. Transplantation 78: 1640-1646.
31. Heeger, P. S., N. S. Greenspan, S. Kuhlenschmidt, C. Dejelo, D. E. Hricik, J. A. Schulak, and M. Tary-Lehmann. 1999. Pretansplant frequency of donor-specific IFN-γ-producing lymphocytes is a manifestation of immunologic memory and correlates with the risk of posttransplant rejection episodes. J. Immunol. 163: 2267-2275.
32. Augustine, J. J., D. S. Siu, M. J. Clemente, J. A. Schulak, P. S. Heeger, and D. E. Hricik. 2005. Pre-transplant IFN-γ ELISPOTs are associated with post-transplant renal function in African American renal transplant recipients. Am. J. Transplant. 5: 1971-1975.
33. Saiki, R. K., P. S. Walsh, C. H. Levenson, and H. A. Erlich. 1989. Genetic analysis of amplified DNA with immobilized sequence-specific oligonucleotide probes. Proc. Natl. Acad. Sci. USA 86: 6230-6234.
34. Blasczyk, R., U. Hahn, J. Wehling, D. Huhn, and A. Salama. 1995. Complete subtyping of the HLA-A locus by sequence-specific amplification followed by direct sequencing or single-strand conformation polymorphism analysis. Tissue Antigens 46: 86-95.
35. Olerup, O., and H. Zetterquist. 1992. HLA-DR typing by PCR amplification with sequence-specific primers (PCP-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 39: 225-235.
36. + T cells via ELISPOT in PBMC: congnate vs. nonspecific production of the cytokine. J. Immunol. Methods 279: 111-121.
37. Gebauer, B. S., D. E. Hricik, A. Atallah, K. Bryan, J. Riley, M. Tary-Lehmann, N. S. Greenspan, C. Dejelo, B. O. Boehm, B. J. Hering, and P. S. Heeger. 2002. Evolution of the enzyme-linked immunosorbent spot assay for post-transplant alloreactivity as a potentially useful immune monitoring tool. Am. J. Transplant. 2: 857-866.
38. Poggio, E. D., M. Clemente, D. E. Hricik, and P. S. Heeger. 2006. Panel reactive T cells as a measurement of primed cellular alloimmunity in kidney transplant candidates. J. Am. Soc. Nephrol. 17: 564-572.
39. Vermes, I., C. Haanen, H. Steffens-Nakken, and C. Reutelingsperger. 1995. A novel assay for apoptosis: flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled AnnexinV. J. Immunol. Methods 184: 39-51.
40. Bas, J., M. Mestre, J. M. Grinyo, E. Massip, J. Alsina, A. M. Castelao, M. Corominas, and E. Buendia. 1998. Peripheral blood lymphoid subsets and long-term clinical course of kidney recipients: a longitudinal study. Cytometry 34: 103-112.
41. Romeu, A., M. Mestre, L. González, A. Valls, J. Verdaguer, M. Corominas, J. Bas, E. Massip, and E. Buendia. 1992. Lymphocyte immunophenotyping by flow cytometry in normal adults: comparison of fresh whole blood lysis technique, Ficoll-Paque separation and cryopreservation. J. Immunol. Methods 154: 7-10.
42. Racusen, L. C., K. Solez, R. B. Colvin, S. M. Bonsib, M. C. Castro, T. Cavallo, B. P. Croker, A. J. Demetris, C. B. Drachenberg, A. B. Fogo, et al. 1999. The Banff 97 working classification of renal allograft pathology. Kidney Int. 55: 713-723.
43. + regulatory T cells at the single-cell level. Eur. J. Immunol. 35: 1681-1691.
44. Flechner, S. M., P. J. Friend, J. Brockmann, H. R. Ismail, M. Zilvetti, D. Godfard, C. Modlin, B. Mastroianni, K. Savas, A. Devaney, et al. 2005. Alemtuzumab induction and sirolimus plus mycophenolate mofetil maintenance for CNI and steroid-free kidney transplant immunosuppression. Am. J. Transplant. 5: 3009-3014.
45. Neujahr, D. C., C. Chen, X. Huang, J. F. Markmann, S. Cobbold, H. Waldmann, M. H. Sayegh, W. W. Hancock, and L. A. Turka. 2006. Accelerated memory cell homeostasis during T cell depletion and approaches to overcome it. J. Immunol. 176: 4632-4639.
46. + regulatory T cells are spread from dwlwtion by antilymphocyte serum, a polyclonal anti-T cell antibody. J. Immunol. 176: 4125-4132.
47. Zheng, X. X., A. Sanchez-Fueyo, C. Domenig, M. H. Sayegh, and T. B. Strom. 2003. Favorably tipping the balance between cytopathic and regulatory T cells create transplantation tolerance. Immunity 19: 503-514.
48. Rothstein, D. M. 2006. Immunosuppression and regulation: cast in new light? J. Am. Soc. Nephrol. 17: 2644-2646.
49. Pearl, J. P., J. Parris, D. A. Hale, S. C. Hoffmann, W. B. Bernstein, K. L. McCoy, S. J. Swanson, R. B. Mannon, M. Roederer, and A. D. Kirk. 2005. Immunocompetent T-cells with a memory-like phenotype are the dominant cell type following antibody-mediated T cell depletion. Am. J. Transplant. 5: 465-474.
50. Graca, L., S. P. Cobbold, and H. Waldmann. 2002. Identification of regulatory T cells in tolerated allografts. J. Exp. Med. 195: 1641-1646.
51. + T regulatory cell infiltrates. J. Immunol. 172: 5753-5764.
52. + regulatory T cells in the periphery of T cell receptor transgenic mice tolerized to transplants. J. Immunol. 172: 6003-6010.
53. Cavinato, R. A., F. Casiraghi, N. Azzollini, P. Cassis, D. Cugini, M. Mister, A. Pezzotta, S. Aiello, G. Remuzzi, and M. Noris. 2005. Pretransplant donor peripheral blood mononuclear cells infusion induces transplantation tolerance by generating regulatory T cells. Transplantation 79: 1034-1039.